# FDA Inspection 636454 - Avista Pharma Solutions, Inc. dba Cambrex - October 09, 2009

Source: https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/b08d8093-c5a2-4add-801d-fda1b977fdca
Source feed: FDA_Inspections

> FDA Inspection 636454 for Avista Pharma Solutions, Inc. dba Cambrex on October 09, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 636454
- Company Name: Avista Pharma Solutions, Inc. dba Cambrex
- Inspection Date: 2009-10-09
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277419 - 2025-07-03](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/8a4208ef-dcad-47c0-9bbd-2ab3cdc26b19)
- [FDA Inspection 1277419 - 2025-07-03](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/60242fd5-25b3-43a8-96f2-d82c2b2bb19d)
- [FDA Inspection 1128465 - 2020-07-17](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/ee45f26b-b044-435f-9d45-4363448c47de)
- [FDA Inspection 805222 - 2012-10-30](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/8c625197-6012-4859-8f23-fe97d16d6479)

Company: https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/56214bca-3cc9-496a-a019-aab43c351824

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c